Return to Search
EN
Initial treatment for trigeminal neuralgia typically involves medication to alleviate pain. Effective medications often include antiepileptic drugs. Many patients experience a significant reduction in their pain with these medications. If medication effectively controls the patient's pain, it can be used long-term. However, while medication use may be paused during pain-free periods, it is resumed when attacks recur. During the course of treatment, potential side effects must be regularly evaluated under the supervision of a specialist.
Over time, the effectiveness of medication may decrease in many patients, and severe pain attacks may persist despite treatment. In such cases, surgical treatment options should be considered. Surgical treatment options include microvascular decompression (MVD) and percutaneous procedures performed via the foramen ovale (such as balloon compression, radiofrequency ablation, or chemical injections). Microvascular decompression is often the preferred initial surgical method, especially for younger patients with radiologically confirmed vascular compression of the trigeminal nerve. This surgery offers patients the potential for a long-term, often permanent, pain-free life. In this method, the trigeminal nerve is exposed using microsurgical techniques, and blood vessels compressing the nerve are carefully separated and padded with a specialized material. This typically results in long-term pain-free periods for the vast majority of cases.
Another surgical treatment approach involves percutaneous procedures performed via the foramen ovale. In these techniques, a catheter is inserted through the corner of the mouth, advanced through the cheek, and guided through the foramen ovale at the skull base to a position near the trigeminal ganglion. Nerve ablation is then achieved using balloon compression, radiofrequency thermocoagulation, or chemical injection (e.g., glycerol or alcohol). These percutaneous methods are generally quicker to complete and carry lower surgical risks compared to microvascular decompression; however, the duration of pain relief may be shorter compared to MVD.
How is Trigeminal Neuralgia Treated?
Over time, the effectiveness of medication may decrease in many patients, and severe pain attacks may persist despite treatment. In such cases, surgical treatment options should be considered. Surgical treatment options include microvascular decompression (MVD) and percutaneous procedures performed via the foramen ovale (such as balloon compression, radiofrequency ablation, or chemical injections). Microvascular decompression is often the preferred initial surgical method, especially for younger patients with radiologically confirmed vascular compression of the trigeminal nerve. This surgery offers patients the potential for a long-term, often permanent, pain-free life. In this method, the trigeminal nerve is exposed using microsurgical techniques, and blood vessels compressing the nerve are carefully separated and padded with a specialized material. This typically results in long-term pain-free periods for the vast majority of cases.
Another surgical treatment approach involves percutaneous procedures performed via the foramen ovale. In these techniques, a catheter is inserted through the corner of the mouth, advanced through the cheek, and guided through the foramen ovale at the skull base to a position near the trigeminal ganglion. Nerve ablation is then achieved using balloon compression, radiofrequency thermocoagulation, or chemical injection (e.g., glycerol or alcohol). These percutaneous methods are generally quicker to complete and carry lower surgical risks compared to microvascular decompression; however, the duration of pain relief may be shorter compared to MVD.